...
首页> 外文期刊>Journal of chemotherapy >Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations.
【24h】

Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations.

机译:利福昔明在超抑制和亚抑制浓度下对细菌毒力机制的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Rifaximin, a poorly absorbed rifamycin derivative, exhibited time-dependent bactericidal activity and at concentrations as low as 1/32 of the minimum inhibitory concentration (MIC) caused morphological alterations in both susceptible and resistant bacterial strains. Spontaneous rifaximin-resistant clones appeared with an incidence of 2.6 x 10(-7). The percentage of Escherichia coli cells cured of various plasmids ranged from: 4.5-70% (Flac), 0-18% (pBP507), 7.7-43.8% (plasmid carrying ESBL genes) and 22.4-41.6% (plasmid encoding toxin from ETEC mex264). 8.4-18.2 and <0.1-18% of Staphylococcus aureus cells were cured (plasmid-mediated penicillinase), 9.5-58.6% of Morganella morganii (ESBL), 10.6-47.1% Citrobacter freundii (ESBL), 2.3-38.7% of Proteus mirabilis (ESBL) and 14.3-66.6% of Klebsiella pneumoniae (ESBL). Rifaximin reduced plasmid transfer from donor to recipient strains by >99%. The MIC of ceftazidime was reduced (2-4 dilutions) in the presence of rifaximin (0.5 x MIC) in ESBL producing strains. Rifaximin lowered the viability and virulence of the bacteria even though they developed resistance to the compound.In conclusion, the present findings add new features to the microbiological characteristics of rifaximin and suggest that if in vivo pathogens are exposed to sub-MICs of the drug, not only are their physiological functions compromised, but gene virulence and antibiotic resistance are not fully expressed.
机译:利福昔明(一种吸收不良的利福霉素衍生物)表现出随时间变化的杀菌活性,其浓度低至最低抑制浓度(MIC)的1/32时,在易感和耐药菌株中均引起形态学改变。出现抗利福昔明的自发克隆,发生率为2.6 x 10(-7)。各种质粒治愈的大肠杆菌细胞百分比范围为:4.5-70%(Flac),0-18%(pBP507),7.7-43.8%(携带ESBL基因的质粒)和22.4-41.6%(编码ETEC毒素的质粒) mex264)。治愈了8.4-18.2和<0.1-18%的金黄色葡萄球菌细胞(质粒介导的青霉素酶),9.5-58.6%的摩根大摩根菌(ESBL),10.6-47.1%的弗氏柠檬酸杆菌(ESBL),2.3-38.7%的变形杆菌(ESBL)和14.3-66.6%的肺炎克雷伯菌(ESBL)。利福昔明使质粒从供体向受体菌株的转移减少了> 99%。在产生ESBL的菌株中存在利福昔明(0.5 x MIC)的情况下,头孢他啶的MIC降低(2-4倍)。利福昔明降低了细菌的存活力和毒力,即使它们对该化合物产生了抗性。总而言之,目前的发现为利福昔明的微生物学特征增加了新的特征,并表明如果体内病原体暴露于药物的亚MIC下,它们不仅损害了它们的生理功能,而且还没有充分表达基因毒力和抗生素抗性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号